CVE-2023-38950

Katalog CVE

CVSS 7.5 · High KEV · sudah dieksploitasi EPSS 92,5%

Kerentanan Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') pada zkteco biotime. Skor CVSS 3.1 7.5 (High) menurut NVD. Masuk katalog KEV CISA pada 19 Mei 2025, artinya sudah terbukti dieksploitasi.

Deskripsi (NVD)

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.

Rincian

Terbit di NVD

3 Agustus 2023

Terakhir diubah

9 Juli 2026

Status NVD

Analyzed

CVSS 3.1

7.5 (High), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N · uraikan di kalkulator

Jenis kelemahan (CWE)

CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

EPSS (30 hari)

92,5% peluang dieksploitasi; lebih tinggi dari 99,8% CVE lain

Known Exploited Vulnerabilities (CISA)

Nama

ZKTeco BioTime Path Traversal Vulnerability

Masuk KEV

19 Mei 2025

Tenggat CISA

9 Juni 2025 (untuk instansi federal AS)

Ransomware

Belum tercatat

Tindakan wajib

Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

Produk dan versi terdampak

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

• https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2023-38950 pemerintah AS
• https://claroty.com/team82/disclosure-dashboard/cve-2023-38950 advisory pihak ketiga
• https://sploitus.com/exploit?id=PACKETSTORM:177859 exploit
• https://www.fortinet.com/content/dam/fortinet/assets/reports/report-incident-response-middle-east.pdf broken link · deskripsi teknis